Yvan Devaux, PhD is head of the Cardiovascular Research Unit at LIH. Using a thoroughly validated experimental pipeline including both discovery and validation phases, Yvan and his research group aim to identify novel biomarkers of heart and brain conditions such as heart failure, cardiac arrest, and Parkinson disease. His research group focuses on RNAs and particularly noncoding RNAs such as microRNAs, long non-coding RNAs, and circular RNAs.
He founded and chairs the Cardiolinc™ network, a consortium of private, clinical and academic partners investigating the role of non-coding RNAs in cardiac disease.
He is chairing the EU-CardioRNA COST Action CA17129, a H2020-funded network of 100+ research groups from 30 European countries willing to share knowledge to foster the research on the role of RNAs in cardiovascular disease.
The group has several ongoing research projects, which include :
• Identification of novel RNA markers of diabetic cardiomyopathy,
• Identification of noncoding RNAs predictive of outcome after cardiac arrest.
"MICRA is a very
promising biomarker candidate
due to its stability in the blood
allowing a quantification in
says Yvan Devaux, PhD, Head of the Cardiovascular Research Unit (CVRU).
1A-B, rue Thomas Edison
Phone : +352 26 970 300